BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Reyataz atazanavir: Phase I data

The open-label, international Phase I Study 182 trial in 39 evaluable HIV-infected pregnant women between 12-32 weeks of gestation who received once-daily 300 or 400 mg Reyataz plus 100 mg ritonavir showed...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >